Cardiology Update

MARCH 17, 2024

Childhood-onset cardiomyopathies represent a rare and poorly understood subset of cardiac disorders. In a recent study published in the European Heart Journal, investigators delved into the demographics and prognosis of pediatric cardiomyopathy patients within the inaugural European Cardiomyopathy Registry. months (IQR: 11.3–15.3),

Cardiomyopathy 119

Cardiomyopathy Pediatrics Article Heart Failure 119

All About Cardiovascular System and Disorders

DECEMBER 15, 2023

Idiopathic dilated cardiomyopathy Idiopathic dilated cardiomyopathy is a form of dilated cardiomyopathy with unknown etiology characterised by progressive left ventricular dilatation and systolic dysfunction. The incidence of idiopathic dilated cardiomyopathy varies from 3-10 cases per 100,000 population.

Cardiomyopathy 52

Cardiomyopathy General Cardiology 52

All About Cardiovascular System and Disorders

APRIL 30, 2024

Hypertrophic cardiomyopathy is a genetic disorder with a guarded prognosis which occurs in about 1:500 individuals. The most common symptom of hypertrophic cardiomyopathy is dyspnoea which occurs in 90% of cases and is due to elevated left ventricular diastolic pressures as a consequence of the diastolic dysfunction.

Cardiomyopathy 40

Cardiomyopathy Bicuspid/Mitral Document Arrhythmia 40

All About Cardiovascular System and Disorders

MAY 8, 2024

2024 ACC/AHA/Multisociety Guidelines for Management of Hypertrophic Cardiomyopathy is now available online with free access at JACC website. Those who are in a hurry could go through the 2024 Hypertrophic Cardiomyopathy Guideline-at-a-Glance which is a five page document which summarises top ten take home messages from the guidelines.

Cardiomyopathy 40

Cardiomyopathy Download Heart Rhythm Document 40

Cardiology Update

AUGUST 4, 2024

The primary outcome is the GDMT prescription rate score, with secondary outcomes covering the time to full GDMT optimization, patient and clinician satisfaction, time spent on healthcare, and the Kansas City Cardiomyopathy Questionnaire.

Heart Failure 119

Heart Failure ACE Inhibitor COVID-19 Quality of Life 119

All About Cardiovascular System and Disorders

MAY 14, 2024

Mavacamten is now approved for treatment of symptomatic hypertrophic obstructive cardiomyopathy and endorsed by mult-society guidelines. Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy was published in 2023, with 28 patients on aficamten 13 on placebo. J Am Coll Cardiol. 2023 Jan 3;81(1):34-45.

Cardiomyopathy 40

Cardiomyopathy Biomarkers Heart Failure General Cardiology 40

All About Cardiovascular System and Disorders

FEBRUARY 25, 2024

When non-compaction is associated with left ventricular dysfunction it is called left ventricular non-compaction cardiomyopathy. Blood flow into and out of these recesses can provide a spectacular view on colour Doppler echocardiography, almost looking like flames of fire near the apex, in the apical four chamber view.

Sudden Cardiac Death 52

Sudden Cardiac Death Heart Failure Cardiomyopathy Arrhythmia 52